{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:38:27Z","timestamp":1761183507248,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.dmpk.2017.04.002","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T10:01:17Z","timestamp":1493546477000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase"],"prefix":"10.1016","volume":"32","author":[{"given":"Takeshi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Otaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Mizuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Onomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihide","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko N.","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2017.04.002_bib1","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1552-4604.1980.tb02544.x","article-title":"Albumin binding interaction of sodium valproate","volume":"20","author":"Fleiman","year":"1980","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/clpt.1990.144","article-title":"Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid","volume":"48","author":"Levy","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmpk.2017.04.002_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0090-9556(24)15311-1","article-title":"Panipenem, a carbapenem antibiotic, enhances the glucuronidation of intravenously administered valproic acid in rats","volume":"27","author":"Yamamura","year":"1990","journal-title":"Drug Metab Disp"},{"key":"10.1016\/j.dmpk.2017.04.002_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jac\/39.2.295","article-title":"Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem\/betamipron","volume":"39","author":"Nagai","year":"1997","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.dmpk.2017.04.002_bib5","first-page":"241","article-title":"Overview of a new carbapenem, panipenem\/betamipron","volume":"20","author":"Shimada","year":"1994","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.dmpk.2017.04.002_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/j.1875-9114.1997.tb03742.x","article-title":"Meropenem, a new carbapenem antibiotic","volume":"17","author":"Fish","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.dmpk.2017.04.002_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/42.4.563","article-title":"Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin","volume":"42","author":"De Turck","year":"1998","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.dmpk.2017.04.002_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00007691-199808000-00008","article-title":"Panipenem-betamipron and decreases in serum valproic acid concentration","volume":"20","author":"Yamagata","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.dmpk.2017.04.002_bib9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","article-title":"Meropenem decreases serum level of valproic acid","volume":"31","author":"Nacarkucuk","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.1E358","article-title":"Acute seizures due to a probable interaction between valporic acid and meropenem","volume":"39","author":"Coves-Orts","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.dmpk.2017.04.002_bib11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00134-005-2695-0","article-title":"Pharmacokinetic interaction between valproic acid and meropenem","volume":"31","author":"Clause","year":"2005","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.dmpk.2017.04.002_bib12","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decrease in a dose-independent manner following administration of meropenem: a retrospective study","volume":"49","author":"Haroutiunian","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/DMDI.2009.24.2-4.153","article-title":"Valproic acid-carbapenem interaction: report of six cases and a review of the literature","volume":"24","author":"Tobin","year":"2009","journal-title":"Drug Metab Drug Interact"},{"key":"10.1016\/j.dmpk.2017.04.002_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejpn.2014.12.010","article-title":"Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics","volume":"19","author":"Herrero","year":"2015","journal-title":"Eur J Paediat Neurol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib15","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1124\/dmd.110.034231","article-title":"Characterization of inhibitory effect of carbapenem antibiotics on the deconjugation of valproic acid glucuronide","volume":"38","author":"Masuo","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2017.04.002_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1124\/dmd.104.000661","article-title":"Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkey and rats","volume":"32","author":"Nakajima","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2017.04.002_bib17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1124\/dmd.110.032938","article-title":"Identification of valproic acid glucuronide hydrolase as a key enzyme for the interaction of valproic acid with carbapenem antibiotics","volume":"38","author":"Suzuki","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2017.04.002_bib18","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3109\/00498254.2011.596582","article-title":"Inhibition mechanism of carbapenem antibiotics on acylpeptide hydrolase, a key enzyme in the interaction with valproic acid","volume":"41","author":"Suzuki","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2017.04.002_bib19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/00498254.2015.1054002","article-title":"In\u00a0vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs","volume":"46","author":"Suzuki","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmpk.2017.04.002_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/jmbi.1993.1531","article-title":"Crystallization and preliminary X-ray studies of human erythrocyte acylpeptide hydrolase","volume":"233","author":"Feese","year":"1993","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib21","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1107\/S1744309105029222","article-title":"Crystallization and preliminary crystallographic analysis of procine acylaminoacyl peptidase","volume":"61","author":"Wright","year":"2005","journal-title":"Acta Crystallog Sect F"},{"key":"10.1016\/j.dmpk.2017.04.002_bib22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.1099736","article-title":"Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone","volume":"305","author":"Williams","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.dmpk.2017.04.002_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142232","article-title":"Linear interaction energy based prediction of cytochrome P450 1A2 binding affinities with reliability estimation","volume":"10","author":"Capoferri","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dmpk.2017.04.002_bib24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/minf.201400192","article-title":"In silico predictions of drug-drug interactions caused by CYP1A2, 2C9 and 3A4 inhibition \u2013 a Comparative study of virtual screening performance","volume":"34","author":"Kaserer","year":"2015","journal-title":"Mol Inf"},{"key":"10.1016\/j.dmpk.2017.04.002_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jmb.2007.02.025","article-title":"The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity","volume":"368","author":"Kiss","year":"2007","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.dmpk.2017.04.002_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1107\/S1399004714026819","article-title":"Catalytically distinct states captured in a crystal lattice: the substrate-bound and scavenger states of acylaminoacyl peptidase and their implications for functionality","volume":"71","author":"Menyh\u00e1rd","year":"2015","journal-title":"Acta Cryst D"},{"key":"10.1016\/j.dmpk.2017.04.002_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nmeth.3213","article-title":"The I-TASSER suite: protein structure and function prediction","volume":"12","author":"Yang","year":"2015","journal-title":"Nat Methods"},{"key":"10.1016\/j.dmpk.2017.04.002_bib28","doi-asserted-by":"crossref","first-page":"W174","DOI":"10.1093\/nar\/gkv342","article-title":"I-TASSER server: new development for protein structure and function predictions","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.dmpk.2017.04.002_bib29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1016\/j.dmpk.2017.04.002_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2105-9-40","article-title":"I-TASSER server for protein 3D structure prediction","volume":"9","author":"Zhang","year":"2008","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.dmpk.2017.04.002_bib31","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.dmpk.2017.04.002_bib32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.dmpk.2017.04.002_bib33","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/jcc.21265","article-title":"Theoretical study of the prion protein based on the fragment molecular orbital method","volume":"30","author":"Ishikawa","year":"2009","journal-title":"J\u00a0Comput Chem"},{"year":"2008","series-title":"AMBER 10","author":"Case","key":"10.1016\/j.dmpk.2017.04.002_bib34"},{"key":"10.1016\/j.dmpk.2017.04.002_bib35","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.dmpk.2017.04.002_bib36","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J\u00a0Comput Chem"},{"key":"10.1016\/j.dmpk.2017.04.002_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cplett.2009.04.045","article-title":"Fragment molecular orbital calculation with RI-MP2 method","volume":"474","author":"Ishikawa","year":"2009","journal-title":"Chem Phys Let"},{"key":"10.1016\/j.dmpk.2017.04.002_bib38","first-page":"1007","article-title":"Gaussian basis sets for use in correlated molecular calculations. I. The atoms boron through neon and hydrogen","volume":"90","author":"Dunning","year":"1989","journal-title":"J\u00a0Chem Phys"},{"key":"10.1016\/j.dmpk.2017.04.002_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/prot.21945","article-title":"MUSTER: improving protein sequence profile-profile alignments by using multiple sources of structure information","volume":"72","author":"Wu","year":"2008","journal-title":"Proteins"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436717300125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436717300125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:53:37Z","timestamp":1761162817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436717300125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1347436717300125"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2017.04.002","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational study of the competitive binding of valproic acid glucuronide and carbapenem antibiotics to acylpeptide hydrolase","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2017.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}